China has been engaged in the R&D and manufacturing of semi-automatic coagulation analyzers for over a decade, and based on the data from the website of the NMPA, in 2024 and 2025 (as od 15 August), a total of 2 instruments from 2 manufacturers have obtained registration certificates...

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China. Latest news

China has been a large and ever-expanding market for Roche, driving much of the company's international growth, and this week, the firm said several initiatives and developments in that country keep it a crucial strategic market for its diag

Abcam said on Thursday that it has acquired the gene editing platform and oncology product portfolio of Applied StemCell for the research and diagnostic markets.

The US Food and Drug Administration late on Tuesday issued an emergency use authorization for a test from the US Centers for Disease Control and Prevention for the novel coronavirus, 2019-nCoV.

Roche on Thursday reported a 3 percent increase in sales of its diagnostics division in 2019, driven primarily by its immunodiagnostic solutions, which are part of its Centralized and Point of Care Solutions business.

Danaher reported on Thursday a 6 percent year-over-year increase in total sales for the fourth quarter, beating the consensus Wall Street estimate.

AnPac Bio-Medical Science said on Thursday that it has priced its initial public offering of roughly 1.3 million American depositary shares (ADS) at $12 apiece, for total proceeds of around $16.0 million.

BGI and its subsidiary MGI Tech said this week that their ultra-high-throughput sequencer DNBSEQ-T7, a metagenomic sequencing kit for coronaviruses, and 2019 novel coronavirus (2019-nCoV) reverse transcription PCR kit have all received emerg

Guided Therapeutics is kicking off 2020 with a renewed focus. The Norcross, GA-based company is renewing a bid for FDA approval of its painless cervical cancer detection test. GT will also raise funds to enhance sales outside of the U.S. for

Abbott Laboratories has won a nod from FDA for a new alternative surgical technique for the HeartMate 3 Left Ventricular Assist Device (LVAD).

Personalized medicine is also advancing thanks to advances in in vitro diagnostics technology